What's New in the Updated Chemotherapy Administration Safety Standards?February 17th 2017
Recent recent update to ASCO/ONS standards for chemotherapy administration safety include considerations for a safe healthcare environment, treatment planning, patient education, and consent.
Fast Facts for the Frontline: Opioid-Induced ConstipationFebruary 16th 2017
An often over-looked side effect with opioids is opioid-induced constipation. Through communication and collaboration, oncology nurses can help to prevent this adverse event, and manage and correct it when it does occur.
Are You Listening?: Effective Pain Relief Depends on a Personalized AssessmentFebruary 15th 2017
Cancer-related pain is among the most common and difficult symptoms patients confront. Assessing and managing it is also challenging for healthcare practitioners, but asking patients the right questions can help.
Trial Examines Triplet Regimen in Ovarian CancerFebruary 14th 2017
In a current phase II/III clinical trial for patients with advanced, recurrent, platinum-resistant ovarian cancer, the novel agent fasbretablin tromethamine is combined with bevacizumab (Avastin) and either paclitaxel or pegylated liposomal doxorubicin.